Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes

Malecki, M. T., Undas, A., Cyganek, K., Mirkiewicz-Sieradzka, B., Wolkow, P., Osmenda, G., Walus-Miarka, M., Guzik, T. J. and Sieradzki, J. (2007) Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes. Diabetes Care, 30(11), pp. 2899-2901. (doi: 10.2337/dc07-1138) (PMID:17704346)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Guzik, Professor Tomasz
Authors: Malecki, M. T., Undas, A., Cyganek, K., Mirkiewicz-Sieradzka, B., Wolkow, P., Osmenda, G., Walus-Miarka, M., Guzik, T. J., and Sieradzki, J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Diabetes Care
Publisher:American Diabetes Association
ISSN:0149-5992
ISSN (Online):1935-5548
Published Online:26 October 2007

University Staff: Request a correction | Enlighten Editors: Update this record